JPRN-UMIN000041324招募中未知
Early Vascular Response to Ultrathin Biodegradable-Polymer Sirolimus-Eluting Stents for The Treatment of ST-Elevation Myocardial Infarction After Plaque Rupture - BD-SES in STEMI
Showa University School of Medicine, Division of Cardiology, Department of Medicine0 个研究点目标入组 20 人开始时间: 2020年8月6日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 90years-old(—)
- 性别
- All
入选标准
- 未提供
排除标准
- •cardiogenic shock, left main disease at the culprit lesion, reference vessel diameter less than 2.0 or 4.5 mm and more, chronic kidney disease defined as a serum creatinine 2.0 mg/dL and more, maintenance dialysis, life expectancy less than two years, planned surgery within three months, adverse reactions to aspirin or clopidogrel previously, warfarin intake before STEMI onset, age less than 20 years, pregnancy, and a previously treated culprit lesion in the stented segment. We further excluded patients who did not undergo OCT, did not show plaque rupture on OCT, and received DES other than BP-SES, patients who do not consent the study.
研究者
相似试验
招募中
不适用
Early vascular healing of ultra-thin strut polymer-free sirolimus eluting stent in acute coronary syndrome: optical coherence tomography studyacute coronary syndromeJPRN-UMIN000042271osaka rosai hospital30
尚未招募
不适用
Vascular Response to Implantation of Drug-eluting Stent in femoropopliteal Artery LesionsPeripheral Artery DiseaseJPRN-UMIN000036499Hyogo College of Medicine20
尚未招募
Unknown
Evaluation of Early Vascular Response following Drug-coated Balloon for Treatment of Coronary Artery Disease as Assessed by Optical Coherence Tomography: the EVALUATION 2 studyChronic coronary syndromeJPRN-UMIN000050640Shinshu University School of Medicine50
招募中
2 期
Clinical trial examining the vascular disrupting agent NPI-2358 combined with docetaxel in patients with advanced non-small cell lung cancer (NSCLC).CTRI/2009/091/000822ereus Pharmaceuticals, Inc.10480 Wateridge CircleSan Diego, CA 92121USA154
尚未招募
不适用
Vascular Response of Orsiro vs. Xience Drug-Eluting Stents for Treating Coronary Bifurcation LesionsCoronary Artery DiseaseNCT05200637Chang Gung Memorial Hospital150
